Pharma Exec Can't Duck SEC's Pump-And-Dump Suit
The Canadian man behind Spencer Pharmaceutical Inc. must face charges from the U.S. Securities and Exchange Commission of spreading fictitious reports of a $245 million buyout to inflate stock prices, a...To view the full article, register now.
Already a subscriber? Click here to view full article